Perfect Medical Health Management Limited (HKG:1830)
Hong Kong · Delayed Price · Currency is HKD 1.300
-0.015 (-1.14%)
Sep 2, 2026, 4:08 PM HKT
HKG:1830 Income Statement
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 962.35 | 1,128 | 1,393 | 1,389 | 1,350 | |
Revenue Growth | -14.67% | -19.05% | 0.29% | 2.91% | 23.88% |
Cost of Revenue | 354.67 | 426.71 | 499.22 | 503.07 | 441 |
Gross Profit | 607.68 | 701.15 | 894.12 | 886.19 | 908.97 |
Selling, General & Admin | 125.96 | 147.9 | 167.76 | 157.23 | 189.22 |
Other Operating Expenses | 108.26 | 124.01 | 143.05 | 136.56 | 116.91 |
Operating Expenses | 387.46 | 450.25 | 512.77 | 517.38 | 525.18 |
Operating Income | 220.23 | 250.9 | 381.35 | 368.81 | 383.79 |
Interest Expense | -7.95 | -11.08 | -11.22 | -12.52 | -16.1 |
Interest & Investment Income | 7.66 | 13.29 | 14.54 | 10.9 | 4.88 |
Currency Exchange Gain (Loss) | 1.04 | -1.9 | -0.48 | -0.37 | 2 |
Other Non Operating Income (Expenses) | -6.34 | -0.18 | - | - | 0.18 |
EBT Excluding Unusual Items | 214.64 | 251.04 | 384.19 | 366.82 | 374.76 |
Gain (Loss) on Sale of Investments | - | - | - | - | -3.05 |
Gain (Loss) on Sale of Assets | -3.77 | 1.51 | -0.47 | -1.1 | 0.13 |
Other Unusual Items | 0.31 | - | - | 25.74 | 6.31 |
Pretax Income | 211.18 | 252.55 | 383.72 | 391.46 | 378.15 |
Income Tax Expense | 32.84 | 46.18 | 73.32 | 75.82 | 72.91 |
Earnings From Continuing Operations | 178.34 | 206.37 | 310.4 | 315.64 | 305.25 |
Minority Interest in Earnings | 0.39 | 0.53 | 5.4 | - | - |
Net Income | 178.73 | 206.9 | 315.8 | 315.64 | 305.25 |
Net Income to Common | 178.73 | 206.9 | 315.8 | 315.64 | 305.25 |
Net Income Growth | -13.62% | -34.48% | 0.05% | 3.40% | 7.24% |
Shares Outstanding (Basic) | 1,256 | 1,256 | 1,256 | 1,249 | 1,231 |
Shares Outstanding (Diluted) | 1,256 | 1,256 | 1,256 | 1,249 | 1,231 |
Shares Change | - | -0.01% | 0.57% | 1.51% | 5.27% |
EPS (Basic) | 0.14 | 0.16 | 0.25 | 0.25 | 0.25 |
EPS (Diluted) | 0.14 | 0.16 | 0.25 | 0.25 | 0.25 |
EPS Growth | -13.78% | -34.38% | -0.66% | 1.89% | 2.06% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 309.22 | 298.23 | 438.84 | 531.52 | 369.34 |
Free Cash Flow Per Share | 0.25 | 0.24 | 0.35 | 0.43 | 0.30 |
Dividend Per Share | 0.146 | 0.165 | 0.251 | 0.253 | 0.248 |
Dividend Growth | -11.52% | -34.26% | -0.79% | 2.02% | -0.80% |
Gross Margin | 63.15% | 62.17% | 64.17% | 63.79% | 67.33% |
Operating Margin | 22.88% | 22.25% | 27.37% | 26.55% | 28.43% |
Profit Margin | 18.57% | 18.34% | 22.66% | 22.72% | 22.61% |
Free Cash Flow Margin | 32.13% | 26.44% | 31.50% | 38.26% | 27.36% |
EBITDA | 275.69 | 318.4 | 460.25 | 455.08 | 460.78 |
EBITDA Margin | 28.65% | 28.23% | 33.03% | 32.76% | 34.13% |
D&A For EBITDA | 55.47 | 67.49 | 78.9 | 86.26 | 76.99 |
EBIT | 220.23 | 250.9 | 381.35 | 368.81 | 383.79 |
EBIT Margin | 22.88% | 22.25% | 27.37% | 26.55% | 28.43% |
Effective Tax Rate | 15.55% | 18.29% | 19.11% | 19.37% | 19.28% |